echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Multinational medical enterprises borrowed the platform to quickly "integrate" into China

    Multinational medical enterprises borrowed the platform to quickly "integrate" into China

    • Last Update: 2022-11-26
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    At the 5th CIIE being held in Shanghai, two achievements of Boston Scientific's "localization strategy" were unveiled for the first time, including a "Polaris intravascular ultrasound system" that "imported exhibits were converted to domestic production", and the other was Boston Scientific's first single-use radiofrequency ablation electrode
    for medical devices "Meltwing" developed and produced in China.
    The Expo actively advocates "exhibits become commodities, exhibitors become investors"
    .
    "With the help of the international cooperation platform effect of the Expo, we continue to expand the local circle of friends, embed it in the domestic medical and health ecological chain, and promote global innovation achievements to the Chinese market
    quickly.
    " Zhang Jun, president of Boston Scientific Greater China, told China News Agency: "The four years that the Expo has been getting better and better is also four years
    of accelerated localization and quality improvement in Boston Scientific.
    ” Benefiting from the "Bo effect", many of Boston Scientific's innovative products displayed at the Expo have been turned from exhibits to commodities, such as Ramon thermal steam therapy equipment and disposable prostate hot steam therapy device Remon System, which were approved and put into clinical practice in China this year, and their listing process was one and a half to two years earlier than the conventional model
    .
    In addition, there are three previous exhibits that have embarked on the access "highway" and are expected to enter the Chinese market
    in advance.
    This year, Boston Scientific registered Boston Scientific Medical Technology (Shanghai) Co.
    , Ltd.
    , accelerating the pace
    of "exhibitors becoming investors".
    Zhang Jun said: "We will firmly move forward in the direction of continuing to cultivate the local area, comprehensively increase localization efforts in various dimensions such as R&D, introduction, production, and professional education, and coexist with the local medical ecosystem to better meet the unmet needs of Chinese doctors and patients and help achieve the strategic goals of Healthy China 2030
    .
    " ” Thermo Fisher Scientific brought diversified solutions
    to the research, prevention, diagnosis and treatment of various diseases at this Expo.
    It is worth mentioning that the company set up a special achievement display area at the Expo site, detailing the process
    of continuous in-depth localization in China over the years, and working with local partners to promote innovation and sustainable social development 。 Relying on the fruitful results achieved by Thermo Fisher Scientific in recent years in accelerating the localization process, at this Expo, Thermo Fisher Scientific announced that it will complete the local mass production of Axia ChemiSEM scanning electron microscope within this year, the localization of the product not only incorporates many "Chinese elements" in the functional design, but also will be more in line with the habits of local users in terms of use, and further meet the needs
    of customers for domestic high-performance medical products.
    Shihan Feng, President of Thermo Fisher Scientific China, said: "China is Thermo Fisher's second largest market in the world, and our innovation DNA is deeply rooted in
    local development.
    Relying on the open and efficient platform effect of CIIE, we look forward to establishing deeper ties with Chinese partners, and continuously deepening our localization strategy of 'taking root in China, serving China', while continuously introducing leading innovation achievements into China, further improving the industrial ecology and empowering local innovation to go global
    .
    " ” Baxter Medical, a diversified medical technology company, exhibited the ROTURM electric anti-pressure ulcer pad for the first time in the world at the 5th CIIE, and three new continuous renal replacement therapy (CRRT) finished replacement fluids also ushered in the "debut" in China
    .
    "We hope that these new products can be borrowed from the Expo platform to enter the Chinese market
    as soon as possible.
    " Xu Runhong, President of Baxter Healthcare Greater China, said: "Baxter will take a more proactive attitude to undertake and amplify the effect of the Expo, and work with partners such as governments, medical institutions, and industry associations to promote the construction of disease management systems and medical model innovation, so as to bring cutting-edge technologies and products closer to Chinese patients
    .
    " ” In order to deepen its development in China, Baxter has established a full-cycle industrial chain
    covering R&D, intelligent manufacturing, supply to service in China.
    One R&D center and seven production bases invested in China have become an important hub
    for introducing and exporting innovative products and services to China and the Asia-Pacific region.
    "Driven by CIIE, Baxter is 'integrating' into China faster, so as to gain more agile insight into the trend of local medical and health services, meet the diverse needs of Chinese patients, and provide them with more flexible and humanized medical solutions
    .
    " Xu Runhong said
    .
    (End)
    ={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"share:","viewSize":"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body).
    appendChild(createElement('script')).
    src='http://bdimg.
    share.
    baidu.
    com/static/api/js/share.
    js?v=89860593.
    js?cdnversion='+~(-new Date()/36e5)];
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.